CTIS.eu › Cities › Germany › Velbert
Velbert
Germany
18 total trials
6 recruiting
2024-520101-39-00
5
2026-04-01
TROP2 NMR-positive advanced or metastatic non-squamous non-small cell
2024-517553-26-00
5
2025-11-12
Advanced ALK-positive non-small cell lung cancer (NSCLC)
2024-517780-24-00
5
2025-09-18
Lung Cancer
2023-505871-63-00
5
2024-04-08
ER+, HER2- metastatic breast cancer following endocrine and CDK 4/6 in
2023-504141-31-00
4
2024-01-17
Metastatic HR positive, HER2 negative breast cancer
2023-506618-29-00
4
2021-09-22
Advanced ovarian, breast, or prostate cancer
2022-503001-38-01
5
2025-07-08
HR-positive HER-2- negative Breast Cancer
2024-512925-95-00
5
2025-05-16
Advanced/Metastatic Breast Cancer
2024-510947-71-00
5
2022-11-21
Chronic Myeloid Leukemia
2023-503990-39-00
5
2021-09-30
Estrogen Receptor-Positive, HER-2 negative Advanced Breast Cancer
2023-503995-26-00
5
2021-05-11
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
2024-516653-44-00
5
2020-11-30
HER2-Low, Hormone Receptor Positive Breast Cancer which has Progressed
2024-515769-32-00
5
2019-07-02
HR+/HER2- early breast cancer
2023-510357-42-00
5
2019-05-22
hormone receptor (HR)-positive, HER2-negative,
early breast cancer (EB
2023-505981-26-00
5
2015-11-20
Non−Small Cell Lung Cancer
2023-503298-39-00
5
2024-06-13
Metastatic Non-Small Cell Lung Cancer (mNSCLC)
2022-502338-20-00
6
2023-07-28
Polycythemia vera
2023-508443-40-00
5
2020-12-18
Lung Cancer, Non-Small Cell
Showing 1–18 of 18 trials